What is Denali Therapeutics Inc.'s net change in cash?

Denali Therapeutics Inc. (DNLI) reported net change in cash of $182.3M in Q1 2026.

How has Denali Therapeutics Inc.'s net change in cash changed year-over-year?

Denali Therapeutics Inc.'s net change in cash increased by 256.5% year-over-year, from -$116.48M to $182.3M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Denali Therapeutics Inc. DNLI Net Change in Cash

Net Change in Cash at other companies

Eli LillyLLY

-$1.99B-1,035%

Regeneron PharmaceuticalsREGN

-$153.1M-125%

Viking TherapeuticsVKTX

-$47.71M-524%

uniQureQURE

$59.74M+2.4%

BridgeBio PharmaBBIO

$309.88M+321%

BiogenBIIB

$392.2M+108%

Other financials

Income statement

See full

Revenue-—

Operating income-$137.4M+5.6%

Net income-$128.4M+3.4%

EPS (diluted)-$0.69+11.5%

Balance sheet

See full

Cash & equivalents$390.7M+551%

Total debt$40.0M-22.3%

Total equity$926.1M-17.5%

Total assets$1.3B-0.4%

Cash flow

See full

Operating cash flow-$131.2M+0.2%

CapEx$2.5M-51.4%

Free cash flow-$133.7M+2.1%

Valuation

See full

Market cap$3.93B+54.2%

Profitability

See full

Operating margin-37,938%-37,986pp

Net margin-33,121.9%-33,159pp

FCF margin-31,736.3%-31,830pp

Returns & leverage

See full

Return on equity-49.6%+34.2pp

Debt / equity0×0.0×

Current ratio9.3×-0.3×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Denali Therapeutics Inc.'s net change in cash?: Denali Therapeutics Inc. (DNLI) reported net change in cash of $182.3M in Q1 2026.
How has Denali Therapeutics Inc.'s net change in cash changed year-over-year?: Denali Therapeutics Inc.'s net change in cash increased by 256.5% year-over-year, from -$116.48M to $182.3M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.